BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bourebaba N, Marycz K. Hepatic stellate cells role in the course of metabolic disorders development - A molecular overview. Pharmacol Res 2021;170:105739. [PMID: 34171492 DOI: 10.1016/j.phrs.2021.105739] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Yin KL, Li M, Song PP, Duan YX, Ye WT, Tang W, Kokudo N, Gao Q, Liao R. Unraveling the Emerging Niche Role of Hepatic Stellate Cell-derived Exosomes in Liver Diseases. J Clin Transl Hepatol 2023;11:441-51. [PMID: 36643031 DOI: 10.14218/JCTH.2022.00326] [Reference Citation Analysis]
2 Bozhkov AI, Novikova AV, Klimova EM, Ionov IA, Akzhyhitov RA, Kurhuzova NI, Bilovetska SG, Moskalov VB, Haiovyi SS. Vitamin A Reduces the Mortality of Animals with Induced Liver Fibrosis by Providing a Multi-level Body Defense System. J Clin Exp Hepatol 2023;13:48-63. [PMID: 36647402 DOI: 10.1016/j.jceh.2022.09.006] [Reference Citation Analysis]
3 Wu J, Zhang M, Xia S, Han P, Zhao K, Peng K, Zhou W, Tian D, Liao J, Liu J. Hepatic HRC induces hepatocyte pyroptosis and HSCs activation via NLRP3/caspase-1 pathway. J Mol Med (Berl) 2022;100:1787-99. [PMID: 36371595 DOI: 10.1007/s00109-022-02270-8] [Reference Citation Analysis]
4 Hunt NJ, Wahl D, Westwood LJ, Lockwood GP, Le Couteur DG, Cogger VC. Targeting the liver in dementia and cognitive impairment: Dietary macronutrients and diabetic therapeutics. Adv Drug Deliv Rev 2022;190:114537. [PMID: 36115494 DOI: 10.1016/j.addr.2022.114537] [Reference Citation Analysis]
5 Sun Y, Cai S, Zhang Y, Ma N, Yi J, Hu X, Wang T. Protective Effect of Rhus chinensis Mill. Fruits on 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine-Induced Cholestasis in Mice via Ameliorating Oxidative Stress and Inflammation. Nutrients 2022;14:4090. [PMID: 36235742 DOI: 10.3390/nu14194090] [Reference Citation Analysis]
6 Wu M, Liu C, Lee S, Kuo Y, Hsieh T. N-Octyl Caffeamide, a Caffeic Acid Amide Derivative, Prevents Progression of Diabetes and Hepatic Steatosis in High-Fat Diet Induced Obese Mice. IJMS 2022;23:8948. [DOI: 10.3390/ijms23168948] [Reference Citation Analysis]
7 Zou L, Shi C, Wang D, Cheng J, Wang Q, Wang L, Yang G. Long non-coding RNA-non-coding RNA activated by DNA damage inhibition suppresses hepatic stellate cell activation via microRNA-495-3p/sphingosine 1-phosphate receptor 3 axis. Bioengineered 2022;13:6150-62. [PMID: 35200103 DOI: 10.1080/21655979.2022.2037841] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Tanaka M, Takahashi S, Higashiura Y, Sakai A, Koyama M, Saitoh S, Shimamoto K, Ohnishi H, Furuhashi M. Circulating level of fatty acid-binding protein 4 is an independent predictor of metabolic dysfunction-associated fatty liver disease in middle-aged and elderly individuals. J Diabetes Investig 2021. [PMID: 34889064 DOI: 10.1111/jdi.13735] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
9 Sousa-Lima I, Kim HJ, Jones J, Kim YB. Rho-Kinase as a Therapeutic Target for Nonalcoholic Fatty Liver Diseases. Diabetes Metab J 2021;45:655-74. [PMID: 34610720 DOI: 10.4093/dmj.2021.0197] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Marycz K. The Hepatic Stellate Cells (HSCs) and Adipose Derived Stem Progenitor Cells (ASCs): are they Critical Multitargeted Endogenous Metabolic Modulators in syndrome X and EMS? Letter to Editor. Stem Cell Rev Rep 2021. [PMID: 34386898 DOI: 10.1007/s12015-021-10233-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]